From Casetext: Smarter Legal Research

Allergan, Inc. v. Watson Labs., Inc.

United States Court of Appeals for the federal Circuit
May 1, 2012
2012-1310 (Fed. Cir. May. 1, 2012)

Opinion

2012-1310

05-01-2012

ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO PHARMACEUTICALS SOLUTIONS, INC., and SUPERNUS PHARMACEUTICALS, INC., Plaintiffs-Appellants, v. WATSON LABORATORIES, INC. - FLORIDA, Defendant-Appellee, and SANDOZ, INC., Defendant-Appellee, and PADDOCK LABORATORIES, INC., Defendant-Appellee.


NOTE: This order is nonprecedential.


Appeal from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0511, Chief Judge Gregory M. Sleet.

ON MOTION

ORDER

Sandoz Inc. moves for reconsideration of this court's April 27, 2012 order expediting the briefing schedule.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion for reconsideration is denied.

FOR THE COURT

______________

Jan Horbaly

Clerk
cc: Jonathan E. Singer, Esq.

Charles A. Weiss, Esq.

Deanne E. Maynard, Esq.

Wendy M. Ward, Esq.
s8


Summaries of

Allergan, Inc. v. Watson Labs., Inc.

United States Court of Appeals for the federal Circuit
May 1, 2012
2012-1310 (Fed. Cir. May. 1, 2012)
Case details for

Allergan, Inc. v. Watson Labs., Inc.

Case Details

Full title:ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO…

Court:United States Court of Appeals for the federal Circuit

Date published: May 1, 2012

Citations

2012-1310 (Fed. Cir. May. 1, 2012)